Scientists reveal eight new molecules, five of which are already US FDA-approved, that can block the polymerase reaction SARS-CoV-2 uses to replicate its genome.
List view / Grid view
Columbia University School of Engineering and Applied Science
Filter the results
A new study has demonstrated for the first time that mutations that affect myosin motor activity result in slower cell movements in vivo.